Recognition of bacterial endotoxins by receptor-dependent mechanisms - PubMed (original) (raw)
Review
Recognition of bacterial endotoxins by receptor-dependent mechanisms
R J Ulevitch. Adv Immunol. 1993.
Abstract
Research performed during the past 5 years has provided a considerable amount of evidence to support the contention that the initial interaction of LPS (lipid A) with cells is mediated by distinct plasma membrane proteins. Some of these interactions may be solely involved in removal and eventual degradation of LPS whereas others may play a critical role in transmembrane signaling. Interactions that appear to be limited to a removal function have been assigned to the lipoprotein scavenger receptor or CD18 where R-form LPS, lipid A, or partial lipid A structures such as lipid IVa appear to be the preferred ligands; S-form LPS appears not to interact with these membrane proteins. Whether these interactions reflect events that occur in vivo remains to be definitively established. Moreover, the scavenger receptor and CD18 do not have a role in mediating LPS-induced transmembrane signaling. Photochemical crosslinking studies performed by Morrison and colleagues and by Dziarski (1991a,b) have revealed an LPS-binding membrane protein with an apparent molecular weight 70,000-80,000. This protein binds the lipid A of LPS as well as the carbohydrate backbone of peptidoglycan. Studies with monoclonal antibodies to this protein show that the presence of antibody blocks LPS binding, suggesting that engagement of this protein leads to transmembrane signaling. However, a definitive evaluation of the role of this protein in mediating LPS effects will require complete purification and/or gene cloning. Perhaps the most important advance in our understanding of how LPS acts is derived from the studies of Ulevitch, Tobias, and colleagues wherein the LBP/CD14-dependent pathway of cell stimulation has been identified. This pathway has particular importance for LPS recognition and signaling by cells such as monocytes/macrophages or polymorphonuclear leukocytes that constitutively express CD14. The importance of the LBP/CD14-dependent pathway has been definitively demonstrated by experiments using immunologic, biochemical, and molecular biologic approaches. Available data are consistent with a model for a heterodimeric LPS receptor that consists of CD14 and an as yet unidentified additional protein(s). Clearly a major goal for future research will be to elucidate fully the additional proteins involved in recognition of LPS.
Similar articles
- Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin.
Ulevitch RJ, Tobias PS. Ulevitch RJ, et al. Annu Rev Immunol. 1995;13:437-57. doi: 10.1146/annurev.iy.13.040195.002253. Annu Rev Immunol. 1995. PMID: 7542010 Review. - CD11/CD18 and CD14 share a common lipid A signaling pathway.
Ingalls RR, Monks BG, Savedra R Jr, Christ WJ, Delude RL, Medvedev AE, Espevik T, Golenbock DT. Ingalls RR, et al. J Immunol. 1998 Nov 15;161(10):5413-20. J Immunol. 1998. PMID: 9820516 - Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway.
Kitchens RL, Ulevitch RJ, Munford RS. Kitchens RL, et al. J Exp Med. 1992 Aug 1;176(2):485-94. doi: 10.1084/jem.176.2.485. J Exp Med. 1992. PMID: 1380063 Free PMC article. - Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein.
Lee JD, Kato K, Tobias PS, Kirkland TN, Ulevitch RJ. Lee JD, et al. J Exp Med. 1992 Jun 1;175(6):1697-705. doi: 10.1084/jem.175.6.1697. J Exp Med. 1992. PMID: 1375269 Free PMC article. - Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation.
Tobias PS, Ulevitch RJ. Tobias PS, et al. Immunobiology. 1993 Apr;187(3-5):227-32. doi: 10.1016/S0171-2985(11)80341-4. Immunobiology. 1993. PMID: 7687234 Review.
Cited by
- The lipopolysaccharide from Capnocytophaga canimorsus reveals an unexpected role of the core-oligosaccharide in MD-2 binding.
Ittig S, Lindner B, Stenta M, Manfredi P, Zdorovenko E, Knirel YA, dal Peraro M, Cornelis GR, Zähringer U. Ittig S, et al. PLoS Pathog. 2012;8(5):e1002667. doi: 10.1371/journal.ppat.1002667. Epub 2012 May 3. PLoS Pathog. 2012. PMID: 22570611 Free PMC article. - Bactericidal/permeability-increasing protein promotes complement activation for neutrophil-mediated phagocytosis on bacterial surface.
Nishimura H, Gogami A, Miyagawa Y, Nanbo A, Murakami Y, Baba T, Nagasawa S. Nishimura H, et al. Immunology. 2001 Aug;103(4):519-25. doi: 10.1046/j.1365-2567.2001.01263.x. Immunology. 2001. PMID: 11529944 Free PMC article. - Saturable CD14-dependent binding of fluorescein-labeled lipopolysaccharide to human monocytes.
Troelstra A, Antal-Szalmas P, de Graaf-Miltenburg LA, Weersink AJ, Verhoef J, Van Kessel KP, Van Strijp JA. Troelstra A, et al. Infect Immun. 1997 Jun;65(6):2272-7. doi: 10.1128/iai.65.6.2272-2277.1997. Infect Immun. 1997. PMID: 9169763 Free PMC article. - Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14.
Loppnow H, Stelter F, Schönbeck U, Schlüter C, Ernst M, Schütt C, Flad HD. Loppnow H, et al. Infect Immun. 1995 Mar;63(3):1020-6. doi: 10.1128/iai.63.3.1020-1026.1995. Infect Immun. 1995. PMID: 7532623 Free PMC article. - Porphyromonas gingivalis lipopolysaccharide-stimulated bone resorption via CD14 is inhibited by broad-spectrum antibiotics.
Miyata Y, Takeda H, Kitano S, Hanazawa S. Miyata Y, et al. Infect Immun. 1997 Sep;65(9):3513-9. doi: 10.1128/iai.65.9.3513-3519.1997. Infect Immun. 1997. PMID: 9284114 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials
Miscellaneous